Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects

NeuroImage

Volumn 37, Issue 4, 2007, Pages 1437-1444

  Caldú, Xavier ^a,b   Vendrell, Pere ^a,b   Bartrés Faz, David ^a,b   Clemente, Inmaculada ^a   Bargalló, Núria ^b,c   Jurado, María Ángeles ^a   Serra Grabulosa, Josep Maria ^a   Junqué, Carme ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE TRANSPORTER; METHIONINE; VALINE; DOPAMINE;

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN REGION; COGNITION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENOTYPE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TANDEM REPEAT; WISCONSIN CARD SORTING TEST; ADOLESCENT; ALLELE; GENETICS; IMAGE PROCESSING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; SYNAPTIC TRANSMISSION; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; ALLELES; CATECHOL O-METHYLTRANSFERASE; COGNITION; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MINISATELLITE REPEATS; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; SYNAPTIC TRANSMISSION;

EID: 34548522297     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.06.021     Document Type: Article

References (55)

1. Bertolino A., Blasi G., Latorre V., Rubino V., Rampino A., Sinibaldi L., Caforio G., Petruzzella V., Pizzuti A., Scarabiono T., Nardini M., Weinberger D.R., and Dallapiccola B. Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J. Neurosci. 26 (2006) 3918-3922
2. Biederman J., and Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 366 (2005) 237-248
3. Braver T.S., Barch D.M., and Cohen J.D. Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol. Psychiatry 46 (1999) 312-328
4. Bruder G.E., Keilp J.G., Xu H., Shikhman M., Schori E., Gorman J.M., and Gilliam T.C. Catechol-o-methyltransferase (COMT) genotypes and working-memory: associations with differing cognitive operations. Biol. Psychiatry 58 (2005) 901-907
5. Callicott J.H., Mattay V.S., Bertolino A., Finn K., Coppola R., Frank J.A., Goldberg T.E., and Weinberger D.R. Physiological characteristics of capacity constraint in working memory as revealed by functional MRI. Cereb. Cortex 9 (1999) 20-26
6. Callicott J.H., Mattay V.S., Verchinski B.A., Marenco S., Egan M.F., and Weinberger D.R. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am. J. Psychiatry 160 (2003) 2209-2215
7. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., Kolachana B.S., Hyde T.M., Herman M.M., Apud J., Egan M.E., Kleinman J.E., and Weinberger D.R. Functional analysis of genetic variation in catechol-o-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 75 (2004) 807-821
8. Conners C.K. Continuous Performance Test II (2004), Multi-Health System, Inc., Toronto
9. Cook E.H., Stein M.A., Krasowski M.D., Cox N.J., Olkon D.M., Kieffer J.E., and Leventhal B.L. Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56 (1995) 993-998
10. Cornish K.M., Manly T., Savage R., Swanson J., Morisano D., Butler N., Grant C., Cross G., Bentley L., and Hollis C.P. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol. Psychiatry 10 (2005) 686-698
11. Cropley V.L., Fujita M., Innis R.B., and Nathan P.J. Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol. Psychiatry 59 (2006) 898-907
12. 158Met polymorphism is associated with cognitive performance in nondemented adults. J. Cogn. Neurosci. 17 (2005) 1018-1025
13. Dougherty D.D., Bonab A.A., Spencer T.J., Rauch S.L., Madras B.K., and Fischman A.J. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354 (1999) 2132-2133
14. 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. 98 (2001) 6917-6922
15. Epstein J.N., Erkanli A., Conners C.K., Klaric J., Costello J.E., and Angold A. Relations between Continuous Performance Tests performance measures and ADHD behaviours. J. Abnorm. Child Psychol. 31 (2003) 543-554
16. Feingold A. The validity of the information and vocabulary subtests of the WAIS. J. Clin. Psychol. 38 (1982) 169-174
17. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV. Axis 1 Disorders (1998), Biometrics Research Department, New York State Psychiatric Institute, New York Non-patient Edition
18. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., and Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J. 1 (2001) 152-156
19. Gazzaley A., Rissman J., and D'Esposito M. Functional connectivity during working memory maintenance. Cogn. Affect. Behav. Neurosci. 4 (2004) 580-599
20. Gill M., Daly G., Heron S., Hawi Z., and Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol. Psychiatry 2 (1997) 311-313
21. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., Lee K.S., Linnoila M., and Weinberger D.R. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22 (2000) 133-139
22. Ho B.C., Wassink T.H., O'Leary D.S., Sheffield V.C., and Andreasen N.C. Catechol-o-methyltransferase Val158Met polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol. Psychiatry 229 (2005) 287-298
23. Joober R., Gauthier J., Lal S., Bloom D., Lalonde P., and Rouleau G. Catechol-o-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch. Gen. Psychiatry 59 (2002) 662-663
24. Kang A.M., Palmatier M.A., and Kidd K.K. Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3). Biol. Psychiatry 46 (1999) 151-160
25. Kieling C., Roman T., Doyle A.E., Hutz M.H., and Rohde L.A. Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biol. Psychiatry 60 (2006) 1163-1165
26. Krause K.H., Dresel S.H., Krause J., La Fougere C., and Ackenheil M. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 27 (2003) 605-613
27. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-o-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
28. Lezak M.D., Howieson D.B., and Loring D.W. Neuropsychological Assessment. 4th ed. (2004), Oxford Univ. Press, New York
29. Lie C.H., Specht K., Marshall J.C., and Fink G.R. Using fMRI to decompose the neural processes underlying the Wisconsin Card Sorting Test. NeuroImage 30 (2006) 1038-1049
30. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melén K., Julkunen I., and Takinen J. Kinetics of human soluble and membrane-bound catechol-o-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
31. Madras B.K., Miller G.M., and Fischman A.J. The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD). Behav. Brain Res. 130 (2002) 57-63
32. Madras B.K., Miller G.M., and Fischman A.J. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol. Psychiatry 57 (2005) 1397-1409
33. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., and Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry 159 (2002) 652-654
34. Martínez D., Gelernter J., Abi-Dargham A., Van Dyck C.H., Kegeles L., Innis R.B., and Laruelle M. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 24 (2001) 553-560
35. Mattay V.S., Tessitore A., Callicott J.H., Bertolino A., Goldberg T.E., Chase T.N., Hyde T.M., and Weinberger D.R. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann. Neurol. 51 (2002) 156-164
36. Mill J., Asherson P., Browes C., D'Souza U., and Craig I. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am. J. Med. Genet. 114 (2002) 975-979
37. Monchi O., Petrides M., Petre V., Worsley K., and Dagher A. Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J. Neurosci. 21 (2001) 7733-7741
38. Numata S., Ueno S., Iga J., Yamauchi K., Hongwei S., Kinouchi S., Shibuya-Tayoshi S., Tayoshi S., Aki H., Sumitani S., Itakura M., and Ohmori T. Interaction between catechol-o-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia. J. Neural Transm. 114 (2007) 255-259
39. Paolo A.M., Axelrod B.N., Troster A.I., Blackwell K.T., and Koller W.C. Utility of a Wisconsin Card Sorting Test short form in persons with Alzheimer's and Parkinson's disease. J. Clin. Exp. Neuropsychol. 18 (1996) 892-897
40. Reuter M., Peters K., Schroeter K., Koebke W., Lenardon D., Bloch B., and Hennig J. The influence of the dopaminergic system on cognitive functioning: a molecular genetic approach. Behav. Brain Res. 164 (2005) 93-99
41. Reuter M., Schmitz A., Corr P., and Hennig J. Molecular genetics support Gray's personality theory: the interaction of COMT and DRD2 polymorphisms predicts the behavioural approach system. Int. J. Neuropsychopharmacol. 9 (2006) 155-166
42. Rosa A., Peralta V., Cuesta M.J., Zarzuela A., Serrano F., Martínez-Larrea A., and Fañanás L. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am. J. Psychiatry 161 (2004) 1110-1112
43. Sano A., Kondoh K., Kakimoto Y., and Kondo I. A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum. Genet. 91 (1993) 405-406
44. Schott B.H., Seidenbecher C.I., Fenker D.B., Lauer C.J., Bunzeck N., Bernstein H.G., Tischmeyer W., Gundelfinger E.D., Heinze H.J., and Düzel E. The dopamine midbrain participates in human episodic memory formation: evidence from genetic imaging. J. Neurosci. 26 (2006) 1407-1417
45. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin C.A., Li X., Jabs E.W., and Uhl G.R. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14 (1992) 1104-1106
46. Vandenberg D.J., Thompson M.D., Cook E.H., Bendahhou E., Nguyen T., Krasowski M.D., Zarrabian D., Comings D., Sellers E.M., Tyndale R.F., George S.R., O'Dowd B.F., and Uhl G.R. Human dopamine transporter gene: coding region among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol. Psychiatry 5 (2000) 283-292
47. Van Dyck C.H., Malison R.T., Jacobsen L.K., Seibyl J.P., Staley J.K., Laruelle M., Baldwin R.M., Innis R.B., and Gelernter J. Increased dopamine transporter availability associated with the 9-repeat allele of SLC6A3 gene. J. Nucl. Med. 46 (2005) 745-751
48. VanNess S.H., Owens M.J., and Kilts C.D. The variable number of tandem repeats element in DAT I regulates in vitro dopamine transporter density. BMC Genet. 6 (2005) 55
49. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gerasimov M., Maynard L., Ding Y.S., Gatley S.J., Gifford A., and Franceschi D. Therapeutic doses of oral methylfenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. 21 RC121 (2001) 1-5
50. Waldman I.D., Rowe D.C., Abramowitz A., Kozel S.T., Mohr J.H., Sherman S.L., Cleveland H.H., Sanders M.L., Gard J.M.C., and Stever C. Association and linkage of dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63 (1998) 1767-1776
51. Weinshilboum R.M., Otterness D.M., and Szumlanski C.L. Methylation pharmacogenetics: catechol-o-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 19-52
52. Wichmann T., and DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6 (1996) 751-758
53. Winstanley C.A., Eagle D.M., and Robbins T.W. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin. Psychol. Rev. 4 (2006) 379-395
54. Witt K., Daniels C., Daniel V., Schmitt-Eliassen J., Volkmann J., and Deuschl G. Patients with Parkinson's disease learn to control complex systems-An indication for intact implicit cognitive skill learning. Neuropsyhologia 44 (2006) 2445-2451
55. Xu H., Kellendonk C.B., Simpson E.H., Keilp J.G., Bruder G.E., Polan H.J., Kandel E.R., and Gilliam T.C. DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability. Schizophr. Res. 90 (2007) 104-107